Opelz Gerhard, Döhler Bernd
1 Department of Transplantation, Immunology, University of Heidelberg, Heidelberg, Germany.
Transplantation. 2016 Jan;100(1):227-32. doi: 10.1097/TP.0000000000000804.
Evidence is limited regarding the effect of stopping smoking before kidney transplantation.
Collaborative Transplant Study data from 46 548 recipients of first kidney transplants (1995-2012) were analyzed to 10 years after transplantation.
Compared with patients who had never smoked (n = 31,462), patients who stopped smoking before transplantation (n = 10,291) only had a modestly increased risk of all-cause graft failure (hazard ratio [HR], 1.1; 95% confidence interval [95% CI], 1.0-1.1; P < 0.001) or death (HR,1.1; 95% CI, 1.0-1.2; P < 0.001) and a similar risk of death-censored graft failure (HR,1.0, 95% CI, 1.0-1.1; P = 0.19), but a 40% increase in death from malignancy (HR, 1.4; 95% CI, 1.2-1.7; P < 0.001). The risk of events was generally markedly higher in patients who continued to smoke (n = 4795) versus those who had stopped. For tumors of the lip, oral cavity and pharynx, digestive organs, respiratory tract, female genitalia and urinary tract, HR values increased significantly from never-smoked to former smokers to current smokers. The risk of respiratory tumors or cervical cancer was approximately halved when smoking was stopped versus continued.
This large series provides clear evidence that patients who stop smoking before transplantation experience substantial benefits, including a substantial reduction in certain types of malignancy.
关于肾移植前戒烟的影响,证据有限。
对来自46548例首次肾移植受者(1995 - 2012年)的协作移植研究数据进行分析,随访至移植后10年。
与从未吸烟的患者(n = 31462)相比,移植前戒烟的患者(n = 10291)全因移植失败风险(风险比[HR],1.1;95%置信区间[95%CI],1.0 - 1.1;P < 0.001)或死亡风险(HR,1.1;95%CI,1.0 - 1.2;P < 0.001)仅适度增加,死亡删失移植失败风险相似(HR,1.0,95%CI,1.0 - 1.1;P = 0.19),但恶性肿瘤死亡风险增加40%(HR,1.4;95%CI,1.2 - 1.7;P < 0.001)。继续吸烟的患者(n = 4795)发生事件的风险通常明显高于戒烟者。对于唇、口腔和咽部、消化器官、呼吸道、女性生殖器和泌尿道肿瘤,HR值从从不吸烟者到既往吸烟者再到当前吸烟者显著增加。与继续吸烟相比,戒烟后呼吸道肿瘤或宫颈癌风险约减半。
这个大型队列研究提供了明确的证据,表明移植前戒烟的患者有显著益处,包括某些类型恶性肿瘤的大幅减少。